Literature DB >> 33044719

Left ventricular mechanics in patients with hematological malignancies before initiation of chemo- and radiotherapy.

Milan Pavlovic1, Aleksandar Dordevic1, Sabine Haßfeld1, Cesare Cuspidi2,3, Hans-Dirk Düngen1, Marijana Tadic4.   

Abstract

Objective We sought to investigate left ventricular (LV) structure, function and mechanics in the patients with leukemia and lymphoma before initiation of chemotherapy, as well as the relationship between hematological malignancies and reduced LV longitudinal strain. Methods This retrospective investigation included 71 patients with leukemia and lymphoma before chemotherapy and 36 healthy controls. All participants underwent echocardiographic examination before initiation of chemotherapy and radiotherapy. Results LV global longitudinal strain (- 20.2 ± 1.7% vs. - 17.9 ± 3.0%, p < 0.001) was significantly lower in the patients with hematological malignancies than in controls. There was no difference in LV circumferential and radial strains between two observed groups. Subendocardial and subepicardial longitudinal strains were significantly lower in the patients with hematological malignancies (- 20.5 ± 3.6% vs. - 22.5 ± 3.8%, p = 0.001 for subendocardial strain; - 18.0 ± 1.5% vs. - 15.8 ± 2.6%, p < 0.001 for subepicardial strain). Hematological malignancies were associated with reduced global LV longitudinal strain (OR 21.0; 95%CI 2.04-215.0, p = 0.010) independently of age, gender, heart rate, body mass index, left ventricular ejection fraction, left ventricular mass index, and glucose level. Conclusions LV longitudinal strain was impaired in the patients with leukemia and lymphoma even before initiation of chemotherapy. Endocardial and epicardial LV layers are equally affected in the patients with hematological malignancies. Newly diagnosed hematological malignancies were related with reduced LV global longitudinal strain independently of common clinical and echocardiographic parameters.

Entities:  

Keywords:  Left ventricle; Leukemia; Lymphoma; Strain

Mesh:

Substances:

Year:  2020        PMID: 33044719     DOI: 10.1007/s10554-020-02061-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  3 in total

1.  Assessing the left atrium of childhood cancer survivors.

Authors:  Robert W Loar; John L Colquitt; Nino C Rainusso; M Monica Gramatges; Asela M Liu; Cory V Noel; Hari P Tunuguntla; Christian Lilje; Ricardo H Pignatelli
Journal:  Int J Cardiovasc Imaging       Date:  2020-08-16       Impact factor: 2.357

2.  Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.

Authors:  Yoshihito Saijo; Kenya Kusunose; Yuichiro Okushi; Hirotsugu Yamada; Hiroaki Toba; Masataka Sata
Journal:  Heart       Date:  2020-03-24       Impact factor: 5.994

3.  Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Rudolf A de Boer; Jean-Sébastien Hulot; Carlo Gabriele Tocchetti; Joseph Pierre Aboumsallem; Pietro Ameri; Stefan D Anker; Johann Bauersachs; Edoardo Bertero; Andrew J S Coats; Jelena Čelutkienė; Ovidiu Chioncel; Pierre Dodion; Thomas Eschenhagen; Dimitrios Farmakis; Antoni Bayes-Genis; Dirk Jäger; Ewa A Jankowska; Richard N Kitsis; Suma H Konety; James Larkin; Lorenz Lehmann; Daniel J Lenihan; Christoph Maack; Javid J Moslehi; Oliver J Müller; Patrycja Nowak-Sliwinska; Massimo Francesco Piepoli; Piotr Ponikowski; Radek Pudil; Peter P Rainer; Frank Ruschitzka; Douglas Sawyer; Petar M Seferovic; Thomas Suter; Thomas Thum; Peter van der Meer; Linda W Van Laake; Stephan von Haehling; Stephane Heymans; Alexander R Lyon; Johannes Backs
Journal:  Eur J Heart Fail       Date:  2020-11-12       Impact factor: 15.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.